Skip to the page

Data / Crowdfunding / New Hampshire / Lodestone Biomedical Inc.

Lodestone Biomedical Inc.: crowdfunding raise on StartEngine Primary, LLC, $14,999 to $1,234,999 (2025)

Lodestone Biomedical Inc., a corporation in Lebanon, NH, filed a Form C with the SEC on January 13, 2025 to raise $14,999 to $1,234,999 in Class B Common Stock through StartEngine Primary, LLC. The offering closed on April 30, 2025. In its most recent fiscal year it reported $946,111 in revenue and a net loss of $69,998, with 5 employees.

SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.

Website
www.lodestonebiomedical.com
Funding portal
StartEngine Primary, LLC
Address
10 WATER STREET SUITE 265, Lebanon, NH 03766
Legal form
Corporation
Jurisdiction
DE
Incorporated
June 17, 2015
SEC CIK
0002044823

Offering terms

From the amendment filed January 13, 2025.

Security
Class B Common Stock
Price
$1.47
Target
$14,999
Maximum
$1,234,999
Deadline
April 30, 2025
Portal compensation
7 - 13 percent

Financials

From the Form C-AR filed May 16, 2025.

Most recent fiscal yearPrior fiscal yearSource
Revenue$946,111$957,211sec.gov
Cost of goods sold$85,578$0sec.gov
Net income$-69,998$-59,274sec.gov
Taxes paid$0$10,315sec.gov
Total assets$110,575$555,177sec.gov
Cash$74,377$251,910sec.gov
Accounts receivable$0$223,878sec.gov
Short-term debt$586,288$1,832,595sec.gov
Long-term debt$5,519$31,315sec.gov

Filings

FiledFilingTargetMaximumDeadlineNoteSource
April 3, 2026Termination of reportingNot listedNot listedsec.gov
May 16, 2025Annual reportNot listedNot listedsec.gov
May 9, 2025Progress update$14,999$1,234,999April 30, 2025At the close of the offering, the issuer closed on $223,878.60 and 178,548 number of securities.sec.gov
January 13, 2025Amendment$14,999$1,234,999April 30, 2025Updated offering with CEO dual employment & IP license disclosures, convertible note details, SE service fee in Use of Proceeds, minor language edits, no insider investments as of 1/13, extended offering end date, and revised minimum funding goal.sec.gov
December 26, 2024Progress update$123,998$1,234,999February 18, 2025The issuer has raised over 100% ($176,970.94) of the offering target amount ($123,998.91).sec.gov
November 18, 2024Offering$123,998$1,234,999February 18, 2025sec.gov

All filings on sec.gov

Updated April 3, 2026. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.